1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legal & IP

Podcast: Legal Expert Advises On Patentable Subject Matter As Courts Send Conflicting Message

Three major cases have provided different interpretations of what is considered patentable subject matter, and to top it off a new guideline from the US Patent and Trademark Office has added to the confusion, according to a legal expert. Harness Dickey’s Chris Cauble walks us through what patent-seekers need to know and how to prepare their patent filings in this interview (podcast and transcript).

3D illustration of rubber stamp with the text patented. IP law and intellectual property patent concept - Illustration

Legal experts say recent court cases and a new guideline from the US Patent and Trademark Office on patent-eligible subject matter have created a lot of ambiguity for companies. The current situation is especially vexing for digital health companies that may want to patent processes and software rather than traditional hardware.

As the medtech industry continues to grapple with the nuances of what is and isn’t patentable, Medtech Insight spoke with Chris Cauble, an attorney with Harness Dickey, to get a...

More from Legal & IP

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.